3 of the best UK shares to buy right now

The London stock market keeps presenting investors with opportunities and I’d buy these three UK stocks right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m considering these three UK shares for my portfolio right now:

Luxury goods

Global luxury goods manufacturer, retailer, and wholesaler Burberry CLSE: BRBY) sells via stores, concessions, outlets, digital commerce, and franchisees in department stores. The company also licenses third parties to manufacture and distribute products using the Burberry trademarks.

In January, the company delivered a robust third-quarter trading update and said full-price sales grew at a double-digit percentage compared with two years earlier. Burberry reckons it is attracting new, younger consumers to the brand. And the directors said they are “confident” of finishing the year strongly.

City analysts have pencilled in an increase in earnings of around 55% for the current trading year to March 2022 followed by a further uplift of around 12% for the year after that. But estimates could be missed if operational challenges arise to thwart progress.

Meanwhile, new chief executive Jonathan Akeroyd starts on 15 March. And new blood at the top could will bring new energy and enthusiasm to drive the business forward.

The share price is near 1,957p as I write and that leads to a forward-looking earnings multiple of just over 19. And the anticipated dividend yield is around 2.7%. That’s not a cheap valuation and could lead to some risk for me as an investor. But Burberry scores well against quality indicators and has growth ambitions. I think the stock would make a promising addition to my long-term portfolio.

Sausage skins

Devro makes collagen products for the food industry around the world — think sausage skins. The company delivered its full-year trading update in January. And the directors said revenue growth at around 5% in 2021 was “encouraging” with positive movements in volume, price, and mix.  

Operating profit will likely be “in line with expectations”. And that means an uplift of about 10% compared to the previous year. Looking ahead, City analysts expect earnings to increase by a mid-single-digit percentage in 2022.

And with the share price near 220p, the forward-looking earnings multiple is about 12 with the anticipated dividend yield around 4.4%.

The valuation looks fair. But I don’t think Devro will ever set my portfolio alight with high growth. Nevertheless, the business operates in a steady, defensive sector and the firm’s dividend record reflects that. The stock looks like a useful hold for the long term and I’d consider it now.

Healthcare

The third stock I’m tempted by today is global healthcare company GlaxoSmithKline (LSE: GSK).

With the final results report on 9 February, chief executive Emma Walmsley said the business ended the year strongly. And the company saw “another quarter of excellent performance driven by first-class commercial execution”. Looking ahead, she said 2022 started with good momentum. And the year will likely deliver “a step-change in growth” and multiple R&D catalysts. The company also plans to demerge its Consumer Healthcare business in 2022.

The recent share price of 1,630p throws up a forward-looking earnings multiple of around 13 when set against analysts’ expectations for a mid-single-digit uplift in earnings in 2023. And the anticipated dividend yield is around 3.3%. I think that valuation looks fair.

There are no guarantees that growth will materialise as expected. But I think GlaxoSmithKline is at an interesting point in its development. And I’d add the stock to my long-term portfolio now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended Burberry, Devro, and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »